However, accumulating evidence over the past two decades demonstrates that a biomarker called C-reactive protein —which ...
Serum C-reactive protein is being investigated as a biomarker to predict adalimumab response in hidradenitis suppurativa patients. Elevated baseline C-reactive protein levels correlate with a reduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback